Structure Therapeutics Chief Commercial Officer John Joseph Berrios files initial beneficial ownership statement

PUBT · 1d ago
Structure Therapeutics Chief Commercial Officer John Joseph Berrios files initial beneficial ownership statement
  • Structure Therapeutics filed a Form 3 for Chief Commercial Officer John Joseph Berrios, disclosing his initial insider holdings as of Aug. 6, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Structure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002148420-26-000005), on August 07, 2026, and is solely responsible for the information contained therein.